Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abeda Inamdar Senior College, Maharashtra
Antifungal agent derived from Streptomyces albidoflavus PU 23
June 15th, 2005
A novel antifungal compound has been derived from a Streptomyces fungus. In a recent study from India, a total of "312 actinomycete strains were isolated from water and soil samples from different regions," and then "purified and screened for their antifungal activity against pathogenic fungi." "Out of these, 22% of the isolates exhibited activity against fungi," reported S.K. Augustine and coauthors at Abeda Inamdar Senior College. "One promising strain, Streptomyces albidoflavus PU 23 with strong antifungal activity against pathogenic fungi, was selected for further studies." "Antibiotic was extracted and purified...
Source: Physician Law Weekly (2005-06-15)
|
